These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 24615122)

  • 1. Early phase clinical trials with human immunodeficiency virus-1 and malaria vectored vaccines in The Gambia: frontline challenges in study design and implementation.
    Afolabi MO; Adetifa JU; Imoukhuede EB; Viebig NK; Kampmann B; Bojang K
    Am J Trop Med Hyg; 2014 May; 90(5):908-14. PubMed ID: 24615122
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The state of immunology in Africa: HIV/AIDS and malaria.
    Leke RG
    Curr Opin Immunol; 2001 Oct; 13(5):523-7. PubMed ID: 11543996
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A systematic review of safety data reporting in clinical trials of vaccines against malaria, tuberculosis, and human immunodeficiency virus.
    Tamminga C; Kavanaugh M; Fedders C; Maiolatesi S; Abraham N; Bonhoeffer J; Heininger U; Vasquez CS; Moorthy VS; Epstein JE; Richie TL
    Vaccine; 2013 Aug; 31(35):3628-35. PubMed ID: 23395586
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Accelerating the development and future availability of HIV-1 vaccines: why, when, where, and how?
    Esparza J; Bhamarapravati N
    Lancet; 2000 Jun; 355(9220):2061-6. PubMed ID: 10885368
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thorny issues in the ethics of AIDS vaccine trials.
    Berkley S
    Lancet; 2003 Sep; 362(9388):992. PubMed ID: 14513850
    [No Abstract]   [Full Text] [Related]  

  • 6. HIV vaccines: a global perspective.
    Esparza J; Osmanov S
    Curr Mol Med; 2003 May; 3(3):183-93. PubMed ID: 12699356
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Convergent ethical issues in HIV/AIDS, tuberculosis and malaria vaccine trials in Africa: Report from the WHO/UNAIDS African AIDS Vaccine Programme's Ethics, Law and Human Rights Collaborating Centre consultation, 10-11 February 2009, Durban, South Africa.
    Mamotte N; Wassenaar D; Koen J; Essack Z
    BMC Med Ethics; 2010 Mar; 11():3. PubMed ID: 20211030
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A 2020 vision for vaccines against HIV, tuberculosis and malaria.
    Rappuoli R; Aderem A
    Nature; 2011 May; 473(7348):463-9. PubMed ID: 21614073
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HIV Vaccines: from basic research to clinical trials--Keystone Symposia.
    Loffredo JT
    IDrugs; 2007 Jun; 10(6):383-7. PubMed ID: 17642000
    [No Abstract]   [Full Text] [Related]  

  • 10. Review of efficacy trials of HIV-1/AIDS vaccines and regulatory lessons learned: A review from a regulatory perspective.
    Sheets RL; Zhou T; Knezevic I
    Biologicals; 2016 Mar; 44(2):73-89. PubMed ID: 26776940
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vaccines under development: group B streptococcus, herpes-zoster, HIV, malaria and dengue.
    da Silva LJ; Richtmann R
    J Pediatr (Rio J); 2006 Jul; 82(3 Suppl):S115-24. PubMed ID: 16721441
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical development of malaria vaccines: should earlier trials be done in malaria endemic countries?
    Chilengi R
    Hum Vaccin; 2009 Sep; 5(9):627-36. PubMed ID: 19617708
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Willingness to participate in AIDS vaccine trials among high-risk populations in northern Thailand.
    Celentano DD; Beyrer C; Natpratan C; Eiumtrakul S; Sussman L; Renzullo PO; Khamboonruang C; Nelson KE
    AIDS; 1995 Sep; 9(9):1079-83. PubMed ID: 8527082
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prospects for vaccines to protect against AIDS, tuberculosis, and malaria.
    Letvin NL; Bloom BR; Hoffman SL
    JAMA; 2001 Feb; 285(5):606-11. PubMed ID: 11176867
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Challenges and strategies for AIDS vaccine development.
    Oxford JS; Frezza P; Race E
    Vaccine; 1993; 11(6):612-4. PubMed ID: 8100664
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The WHO and why of HIV vaccine trials.
    Moore J; Anderson R
    Nature; 1994 Nov; 372(6504):313-4. PubMed ID: 7969482
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progress in AIDS vaccine development.
    Johnston MI
    Int Arch Allergy Immunol; 1995 Dec; 108(4):313-7. PubMed ID: 7580300
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of humoral immune responses in malaria vaccine trials.
    Esen M
    Wien Klin Wochenschr; 2010 Mar; 122 Suppl 1():4-6. PubMed ID: 20376714
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vaccines for preventing malaria.
    Graves P; Gelband H
    Cochrane Database Syst Rev; 2003; (1):CD000129. PubMed ID: 12535387
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Malaria vaccines in development.
    Ballou WR
    Expert Opin Emerg Drugs; 2005 Aug; 10(3):489-503. PubMed ID: 16083325
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.